Member Info for Spuddymadrid

Hello Swizz. Saw the video. Thanks for that. Din’t think it will make any difference the fact that we are in a precarious supply situation in Ireland. I have no hope with ER in place. I have shares in BEY and Landsdowne and have been a shareholder for over a decade. I increased recently quite considerably my holding in LOGP because of better chance of recovering something possibly throught ECT. What do you think is going on ?. Is anything happening behind the scenes ? Has LOGP had any meetings with the Decc or ER or the department ? Do you think we will hear something from LOGP soon ? Do you think their is a constructive plan ? Just wanted to get your view. Take care

I think ER will be happy to settle this now quickly with LOGP given the BEY is out of the way. Depending on what BEY`s plan is it could be a cash settlement or an investment by the govt (in lieu of damages) to get something done in conjunction with BEY.

I attended the ShareSoc webinar yesterday and also asked questions. I have a reasonably large share holding here and obviously do not like seeing the share price at these levels. Poolbeg are in a very good financial position and that is good news for the shareholders. We have many routes opening up to monetization but it is going to take time. Polb-001 is a potential game changer. However it is better to do the CAR-T and Immunology studies and get Polb-001 validated for these treatments. JS also mentioned other possible inflammatory conditions that might possibly be treated with POLB-001. So I believe it will be 2024 before we see a deal on POLB-001 and it could potentially be a very big one. POLB-002 could be partnered at any stage. JS said that they will look for non-dilutive funding to progress it and that in the USA there is interest for this type of RSV treatment. JS spoke about the AI Influenza and RSV studies. He said they are very happy with the results and that the new insights are unique and potentially very valuable to big pharma. A deal will come at some stage for these new AI related vaccines. I think we might see a firming up of the Oral metabolism drug agreement with the unnamed NASDAQ company sooner rather than later. Also believe Oral-GLP and Vaccine domain is going to be a big business for Poolbeg. So the take away is we need to have patience and things will fall into place nicely. I will continue to add as and when I have spare funds !!!

Hello there Cash. Good news this morning. Exciting times ahead for Poolbeg I would say. We have some more near term important news to come. Polb-001 update on out licensing, CAR-T Poolb-001 update, AI clinical testing on RSV and possible update on POLB-002 RSV out licensing amongst other things. Obviously as a shareholder I am biased but I think this company will make us all rich !!!

Could be Novo Nordisk. That would be nice !!!

Hello there Cash

Hoping to hear some news from JS soon. Obviously we need to let the management team do their work correctly and only enter deals at a suitable time. Would be nice though to hear something positive soon and see the price move up. Not so sure we will see anything of importance from JS at the event on Oct 25. Hope I am wrong !!!

Wonder what is going on with POLB-002. I imagine AI work for RSV will also validate POLB-002. Wonder are discussions ongoing for POLB-002 out licensing as well

Agree with you Cash. JS should tell us more about what the state of play on negotiations is. If discussions are indeed taking place he does not have to give specifics but should at least provide some words that help support the share price and provide some comfort to existing shareholders. I would guess that talks are ongoing and that the internal debate is whether to out license POLB-001 based on individual therapies (influenza, car-t, immunology et cetera) or whether to sign an all inclusive deal with a major partner for the lot. I expect and hope we will see interesting and positive news on various fronts before the end of the year. But as Moniman has pointed out as well on many occasions capital light and long runway do not cut the mustard !!

Hello to all

So what news are we expecting in the near future (by year end) that will impact the share price. 1: A possible out license of POLB-001 for Influenza. CAR-T and Immunology deals likely to follow later. News on potential new RSV treatments following AI evaluation. Polb-002 will possibly be validated again with the AI study. So an out license of Polb-002 is a possibility as well. Polb-003 (not sure what to expect or when). Oral encapsulation validation. Possible new in licensing based on RSV AI results. Possible in licensing of new treatments from UCD. Not sure what else is possible or probable this year. Wonder if POLB-001 could be used against Sepsis and Covid cytokine storms as well ?. Wonder what would be the value for Polb-001 in an initial influenza deal (not including all the other possible uses ?. Wonder what the value of POLB-002 is ? Lots of unknowns !!!

Hello Moninan. I think MM are still keeping the price low trying to draw in sellers. They know the share is undervalued. All waiting for a deal. Suppose we just have to be patient. I bought some more this week at 7.4 pence. Take care

Thank you Cash

Thanks Swizz. It will be interesting to see what happens.

Hello Manyana. Is there the possibility that the 1.05 million and the additional 5 million coukd be used to reverse into Logp and this allow for removal of cash shell status. Believe Logp need 6m to get the ball rolling again. Seems a bit of a coincidence that logp need 6m and the Boe rns mentions 6.05m ( initially)

Hello Moniman. Hope all well with you. Do you have any links to any article re Allianz

Hello Moniman. Polb-001 will become more valuable as we add car-t, immunology, perhaps covid other possible treatments to the list. With AI influenza, RS polb-002 and AI plus GLP and oral vaccines going forward this share could be worth much more than 25 cents. But as you have pointed out the proof is in the pudding. We will wait for the deals and potential take over bids after. Patience will hopefully reward us

Agree with you Cashintime. Nothing will happen until a deal is signed. I believe they are now waiting for CAR-T Result and additional oncology uses before signing a deal. However it would be nice if we were told so. What sort of a deal are we talking about is another matter. No idea what POLB -001 is actually worth. Moniman is correct to be sceptical. We can only judge on results. I do believe this will be a fantastic investment in the end but at some stage JS and the team will have to start delivering some deals.

Https://news.sky.com/story/untapped-rosebank-oil-and-gas-field-north-of-scotland-approved-for-development-amid-row-over-climate-damage-12893255

Https://news.sky.com/story/untapped-rosebank-oil-and-gas-field-north-of-scotland-approved-for-development-amid-row-over-climate-damage-12893255

Hello Moniman/ Cash. Agree with you both. We want some deals and no cheap shares for those who have taken no risks.

Hello there Longerwait. Hope you are well today. You may be correct we will see at some stage. However when you insult people like you do it tends to minimize what you are saying. Perhaps you are the only clever one here !!!